Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

s and increasing their risk of developing treatment-related acute myeloid leukemia.

To understand if ibrutinib may be effective for elderly CLL patients and to identify which patients might benefit most from the drug, researchers enrolled 116 CLL patient participants in several treatment cohorts: patients who were never treated (the treatment-nave group), those who had received two or more prior therapies (the relapsed/refractory group), those who had relapsed within two years of treatment (the high-risk group), and those over age 65. Two oral dosing regimens (420 mg or 840 mg daily) of ibrutinib were used. The primary goal of the study was to determine the safety of the low and high doses; secondary objectives included efficacy, measures of the intensity of the drug's effect in the body, and the long-term safety of administering this therapy continuously until relapse.

The study found that response to therapy was high across the cohorts, with largely manageable toxicities. Previously untreated elderly patients responded best to the agent, with 71 percent experiencing a complete or partial response at either treatment dose. The same response was observed in 67 percent of the relapsed patients and 50 percent of the high-risk patient cohort. After 22 months of follow-up, the disease had not progressed in 96 percent of previously untreated patients and 76 percent of relapsed and high-risk patients.

The treatment regimen was generally well-tolerated, as only non-severe side effects were observed, including diarrhea, fatigue, chest infection, rash, nausea, joint pain, and infrequent and transient low blood counts. Investigators found no evidence of cumulative toxicity or long-term safety concerns with a median follow-up of 16 months for treated patients. These results demonstrate ibrutinib's potential as a highly active, well-tolerated first-line therapy for CLL.

"As we learn more about how to target specific essential survival signa
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Parker Waichman LLP, a national law firm dedicated ... devices, is offering remarks on the closing argument of the ... E. Taylor v. Intuitive Surgical, 09-2-03136-5, Superior Court, State of ... Bloomberg report noted that the plaintiff’s attorney, after noting ... how it deployed its strategy to train doctors to use ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Parker Waichman ... rights of victims injured by defective medical devices, is ... & Joint Surgery on May 15, 2013. The study ... to identify complications that occur in patients with metal-on-metal ... failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve ...
(Date:5/21/2013)... 21 May 2013, Paris, France: One-year results from SOURCE ... valve implantation (TAVI) registries to-date reported today at ... practice, with high rates of device success for all ... SOURCE XT Post-Approval Study followed up 2688 consecutively enrolled ... Sapien XT heart valve at 93 centres in 17 ...
(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Wright Conserve hip replacement lawsuits in ... an Order in response to a request from Plaintiffs’ ... of the Defendant. The May 17th Order grants ... interviews may be conducted. (In re: Wright Medical Technology, ...
(Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3
... room in the intensive care unit previously ... may increase the odds of acquiring such ... illness and death in hospitals: methicillin-resistant Staphylococcus ... to background information in the article. Researchers ...
... latest to join the fight against HIV with their services ... have been recruited as part of an innovative program to ... government. This donation is expected to aid in the funding ... testing and encouraging safer sex. ,The British ...
... the HIV/AIDS prevalence rate in Kenya from 6.1% in 2005 ... Council of Kenya (NACC) released the latest data, according to ... % whereas in rural areas it is 4.6%.,A variety of ... pregnant HIV-positive mothers from passing the virus to their babies, ...
... oily fish during pregnancy may increase the risk of ... high mercury levels in oily fish like mackerel, salmon ... experts say that it is essential for everybody including ... ,According to the Food Standards Agency, pregnant ...
... different work places were at higher risk for breast cancer. ... on a farm have a risk of breast cancer that ... study also found out that women working in healthcare and ... cancer than the national average.,This study, conducted by researchers at ...
... a very different kind of war for Prem Khullar. Here ... bacteria, not civilian populations//. And the retired air force squadron ... years. ,What began in 1993 as a one-room ... (ABLE). Made possible through generous NRI funding and local land ...
Cached Medicine News:Health News:Transmission of Antibiotic-Resistant Bacteria Linked to Previous ICU Room Occupants 2Health News:Decrease in AIDS prevalence rate in Kenya 2Health News:Premature Delivery due to Oily fish 2
(Date:5/21/2013)... 21, 2013  IsoRay, Inc. (AMEX: ISR ... entered into an exclusive international distribution agreement with IASIS ... in Greece . IsoRay is a ... medical radioisotope applications for brain cancer, lung cancer, head ... IASIS Medical is ideally suited to ...
(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... DUBLIN, Jan. 11, 2011 Amarin Corporation plc (Nasdaq: ... a focus on cardiovascular disease, today announced that it has ... Shares ("ADSs") at a price to the public of $7.60 ... of the underwriters, over-allotment option, the company sold a total ...
... Newell Robinson, M.D., Chairman of the Department ... Director of Interventional Cardiovascular Procedures; Andrew Berke, M.D., ... at St. Francis Hospital, The Heart Center® are ... a device that may offer new hope for ...
Cached Medicine Technology:Amarin Announces Successful Completion of Offering of American Depositary Shares 2Amarin Announces Successful Completion of Offering of American Depositary Shares 3St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement 2
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Open 14 mm fixation ring with teeth to prevent damage to conjuctiva. Gauge is marked every 10 degrees to determine the extent of the arc to be incised. Two broad marks align with steep axis....
Fixation ring with atraumatic teeth provides excellent stabilization and pressure on globe. Round knurled handle with dull finish....
Medicine Products: